Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 4995
Single User License Price INR 355744
Corporate User License Price USD 14985
Corporate User License Price INR 1067232
Site License Price USD 9990
Site License Price INR 711488
Request a Quote

Report Title

United States Interventional Neuroradiology Market Outlook to 2025

Quote Request for License Type
License Type Price  
Single User License USD 4995
Site License USD 9990
Enterprise Wide License USD 14985
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

United States Interventional Neuroradiology Market Outlook to 2025


Quote Request for License Type
License Type Price  
Single User License USD 4995
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

United States Interventional Neuroradiology Market Outlook to 2025

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

United States Interventional Neuroradiology Market Outlook to 2025



Executive Summary

United States Interventional Neuroradiology Market Outlook to 2025

Summary

GlobalData's new report, United States Interventional Neuroradiology Market Outlook to 2025, provides key market data on the United States Interventional Neuroradiology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Interventional Neuroradiology market segments-Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Interventional Neuroradiology market.

- Global corporate-level profiles of key companies operating within the United States Interventional Neuroradiology market.

- Key players covered include Medtronic plc, Penumbra Inc, Stryker Corp and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Interventional Neuroradiology Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Interventional Neuroradiology Market, United States 8

3.1 Interventional Neuroradiology Market, United States, Revenue (USD m), 2015-2025 8

3.1.1 Neurovascular Accessory Devices Market, United States, Revenue (USD m), by Segment, 2015-2025 11

3.1.2 Neurovascular Coiling Assist Devices Market, United States, Revenue (USD m), by Segment, 2015-2025 13

3.1.3 Neurovascular Embolization Devices Market, United States, Revenue (USD m), by Segment, 2015-2025 15

3.1.4 Neurovascular Thrombectomy Devices Market, United States, Revenue (USD m), by Segment, 2015-2025 18

3.2 Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 20

3.2.1 Neurovascular Accessory Devices Market, United States, Volume (Units), by Segment, 2015-2025 23

3.2.2 Neurovascular Coiling Assist Devices Market, United States, Volume (Units), by Segment, 2015-2025 26

3.2.3 Neurovascular Embolization Devices Market, United States, Volume (Units), by Segment, 2015-2025 29

3.2.4 Neurovascular Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2015-2025 32

3.3 Interventional Neuroradiology Market, United States, Average Price (USD ), 2015-2025 35

3.4 Interventional Neuroradiology Market, United States, Distribution Share by Revenue (USD m), 2017 37

3.5 Interventional Neuroradiology Market, United States, Company Share by Revenue (USD m), 2017 38

4 Overview of Key Companies in United States, Interventional Neuroradiology Market 40

4.1 Medtronic Plc 40

4.1.1 Company Overview 40

4.2 Stryker Corp 40

4.2.1 Company Overview 40

4.3 Penumbra Inc 40

4.3.1 Company Overview 40

4.4 Terumo Corp 41

4.4.1 Company Overview 41

4.5 MIZUHO Co Ltd 41

4.5.1 Company Overview 41

4.6 Cerenovus 41

4.6.1 Company Overview 41

5 Interventional Neuroradiology Market Pipeline Products 42

6 Financial Deals Landscape 43

6.1 Equity Offerings 43

6.1.1 AxoGen Raises USD141.4 Million in Public Offering of Shares 43

6.1.2 AxoGen Raises USD41 Million in Public Offering of Shares 45

7 Recent Developments 47

7.1 Corporate Communications 47

7.1.1 Jul 10, 2018: Stryker announces organizational changes 47

7.1.2 Jul 10, 2018: AxoGen Names Lisa N. Colleran As Board Director 47

7.1.3 Jun 22, 2018: Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson 48

7.1.4 Jun 22, 2018: Johnson & Johnson Appoints Senior Leaders to Executive Committee 48

7.1.5 Jun 13, 2018: Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases 49

7.1.6 Jun 04, 2018: AxoGen Names Kaila Krum Vice President, Investor Relations and Corporate Development 50

7.1.7 May 21, 2018: AxoGen Names Karen Zaderej As Board Chairman 50

7.1.8 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 51

7.1.9 Dec 14, 2017: Cibiem Appoints William H. Kucheman to the Board of Directors 51

7.1.10 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 52

7.1.11 Nov 01, 2017: New Phase 1/2 Study Data for ALXN1210 as a Potential Future Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Be Presented at American Society of Hematology (ASH) Meeting 52

7.1.12 Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida 53

7.2 Financial Announcements 54

7.2.1 Jul 17, 2018: Johnson & Johnson Reports 2018 Second-Quarter Results 54

7.2.2 May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results 55

7.2.3 Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results 56

7.2.4 Apr 26, 2018: Stryker reports first quarter 2018 operating results 57

7.2.5 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 57

7.2.6 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 59

7.2.7 Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results 61

7.2.8 Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results 61

7.2.9 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 62

7.2.10 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 63

7.2.11 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 64

7.2.12 Jan 22, 2018: Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test 66

7.2.13 Jan 09, 2018: Stryker provides 2017 preliminary net sales results 68

7.2.14 Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue 69

7.2.15 Nov 07, 2017: Penumbra Reports Third Quarter 2017 Financial Results 69

7.2.16 Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 70

7.2.17 Oct 26, 2017: Stryker reports third quarter 2017 results 70

7.2.18 Oct 17, 2017: Johnson & Johnson Reports 2017 Third-Quarter Results 72

7.3 Government and Public Interest 73

7.3.1 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 73

7.4 Product News 74

7.4.1 Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day 74

8 Appendix 76

8.1 Research Methodology 77

8.1.1 Coverage 77

8.1.2 Secondary Research 77

8.1.3 Primary Research 78

8.1.4 Market Modeling and Forecasting 79

8.1.5 Company Share Analysis 80

8.1.6 Distribution Share Analysis 81

8.1.7 Benchmarking 81

8.2 GlobalData Consulting 81

8.3 Contact Us 82

8.4 Disclaimer 82

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

1.2 List of Figures

Figure 1: Interventional Neuroradiology Market, United States, Revenue (USD m), USD Constant, 2015-2025 8

Figure 2: Neurovascular Accessory Devices Market, United States, Revenue (USD m), USD Constant, 2015-2025 11

Figure 3: Neurovascular Coiling Assist Devices Market, United States, Revenue (USD m), USD Constant, 2015-2025 13

Figure 4: Neurovascular Embolization Devices Market, United States, Revenue (USD m), USD Constant, 2015-2025 15

Figure 5: Neurovascular Thrombectomy Devices Market, United States, Revenue (USD m), USD Constant, 2015-2025 18

Figure 6: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 20

Figure 7: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2025 23

Figure 8: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2025 26

Figure 9: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2025 29

Figure 10: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2025 32

Figure 11: Interventional Neuroradiology Market, United States, Company Share (%) 2017 38

1.1 List of Tables

Table 1: Interventional Neuroradiology Market, United States, Revenue (USD m), USD Constant, 2015-2020 9

Table 2: Interventional Neuroradiology Market, United States, Revenue (USD m), USD Constant, 2021-2025 10

Table 3: Neurovascular Accessory Devices Market, United States, Revenue (USD m), USD Constant, 2015-2020 12

Table 4: Neurovascular Accessory Devices Market, United States, Revenue (USD m), USD Constant, 2021-2025 12

Table 5: Neurovascular Coiling Assist Devices Market, United States, Revenue (USD m), USD Constant, 2015-2020 14

Table 6: Neurovascular Coiling Assist Devices Market, United States, Revenue (USD m), USD Constant, 2021-2025 14

Table 7: Neurovascular Embolization Devices Market, United States, Revenue (USD m), USD Constant, 2015-2020 16

Table 8: Neurovascular Embolization Devices Market, United States, Revenue (USD m), USD Constant, 2021-2025 17

Table 9: Neurovascular Thrombectomy Devices Market, United States, Revenue (USD m), USD Constant, 2015-2020 19

Table 10: Neurovascular Thrombectomy Devices Market, United States, Revenue (USD m), USD Constant, 2021-2025 19

Table 11: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2020 21

Table 12: Interventional Neuroradiology Market, United States, Volume (Units), 2021-2025 22

Table 13: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2020 24

Table 14: Neurovascular Accessory Devices Market, United States, Volume (Units), 2021-2025 25

Table 15: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2020 27

Table 16: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2021-2025 28

Table 17: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2020 30

Table 18: Neurovascular Embolization Devices Market, United States, Volume (Units), 2021-2025 31

Table 19: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2020 33

Table 20: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2021-2025 34

Table 21: Interventional Neuroradiology Market, United States, Average Price (USD ), 2015-2020 35

Table 22: Interventional Neuroradiology Market, United States, Average Price (USD ), 2021-2025 36

Table 23: Interventional Neuroradiology Market, United States, Distribution Share by Revenue (USD m), USD Constant, 2017 37

Table 24: Interventional Neuroradiology Market, United States, Company Share by Revenue (USD m), USD Constant, 2017 39

Table 25: Interventional Neuroradiology Market Pipeline Products 42

Table 26: AxoGen Raises USD141.4 Million in Public Offering of Shares 43

Table 27: AxoGen Raises USD41 Million in Public Offering of Shares 45

Table 28: Total Number of Primary Research Participants, Neurology Devices Market, by Country 79

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Medtronic Plc

Stryker Corp

Penumbra Inc

Terumo Corp

MIZUHO Co Ltd

Cerenovus

Neurology Devices, Hydrocephalus shunts, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Natus Medical Incorporated, Stryker Corp, Nevro Corp, Cerenovus, Terumo Corp, LivaNova PLC , Nihon Kohden Corp, Penumbra Inc, Integra LifeSciences Corp, B. Braun Melsungen AG, Accuray Inc, Elekta AB


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person